Lakshmi Thangavelu, Saade Abdalkareem Jasim, Fahad Alsaikhan, Supat Chupradit, Wanich Suksatan, Dmitry Olegovich Bokov, Mohammed Abed Jawad, Satish Kumar Sharma
Journal: Current medicinal chemistry 2023;30(33):2726-3742
PMID: 36281859
We are experiencing a revolution in regenerative medicine. Recent developments in organoid technology have provided unique opportunities for studying human biology and diseases. Indeed, organoid models have revolutionized the in vitro culture tools for biomedical research by creating robust three-dimensional (3D) architecture to recapitulate the primary tissues' cellular heterogeneity, structure, and functions. Such organoid technology enables researchers to re-create human organs and diseases model in a culture dish. It thus holds excellent promises for many translational applications such as regenerative medicine, drug discovery, and precision medicine. This review summarizes the current knowledge on the progression and promotion of organoid models, particularly with the heart disease approach. We discuss the usefulness of clinical applications of cardiac organoids and ultimately highlight the currently advanced therapeutic strategies in vitro model of organoids aimed at personalizing heart disease treatment.
Copyright© Bentham Science Publishers; For any queries, please email at [email protected].
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.